Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2021

May 18, 2021

35119_dirs_2021-05-18_3e2ed970-56f8-448c-a92d-66094fe7920c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2021-05-14

Reporting Person: ZELDIS JEROME B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-14 Common Stock P 3000 $0.888 Acquired 25917 Direct
2021-05-14 Common Stock S 3000 $0.9002 Disposed 22917 Direct

Footnotes

F1: The Reporting Person's sale of 3,000 shares of the Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with the purchase of 3,000 shares of the Issuer's common stock reported herein. The Reporting Person has voluntarily agreed to disgorge to the Issuer the full amount of the resulting statutory "profit" calculated pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended.